Corrigendum to: Formulation and evaluation of targeted nanoparticles for breast cancer theranostic system [European Journal of Pharmaceutical Sciences, 97 (2017) 47-54]

ScienceDirect® is a registered trademark of Elsevier B.V.

留言 (0)

沒有登入
gif